These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18716861)

  • 41. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
    Lo J; Xia CQ; Peng R; Clare-Salzler MJ
    J Immunol Res; 2018; 2018():5463879. PubMed ID: 29651443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implication of the CD47 pathway in autoimmune diabetes.
    Dugas V; Beauchamp C; Chabot-Roy G; Hillhouse EE; Lesage S
    J Autoimmun; 2010 Aug; 35(1):23-32. PubMed ID: 20138735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells.
    Bluestone JA; Tang Q
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14622-6. PubMed ID: 15322272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breakdown in peripheral tolerance in type 1 diabetes in mice and humans.
    Jeker LT; Bour-Jordan H; Bluestone JA
    Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a007807. PubMed ID: 22393537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of TGF-β in Self-Peptide Regulation of Autoimmunity.
    Singh B; Krawetz MD; De Lima RM; Mukherjee R; Chaturvedi P; Lee-Chan E; Leiter EH; Summers KL
    Arch Immunol Ther Exp (Warsz); 2018 Feb; 66(1):11-19. PubMed ID: 28733878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BIM Deficiency Protects NOD Mice From Diabetes by Diverting Thymocytes to Regulatory T Cells.
    Krishnamurthy B; Chee J; Jhala G; Trivedi P; Catterall T; Selck C; Gurzov EN; Brodnicki TC; Graham KL; Wali JA; Zhan Y; Gray D; Strasser A; Allison J; Thomas HE; Kay TW
    Diabetes; 2015 Sep; 64(9):3229-38. PubMed ID: 25948683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parameters influencing antigen-specific immunotherapy for type 1 diabetes.
    Wang B; Tisch R
    Immunol Res; 2008; 41(3):175-87. PubMed ID: 18543112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
    Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
    PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.
    You S; Chatenoud L
    Methods Mol Biol; 2016; 1371():117-42. PubMed ID: 26530798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-cell education in autoimmune diabetes: teachers and students.
    Rosmalen JG; van Ewijk W; Leenen PJ
    Trends Immunol; 2002 Jan; 23(1):40-6. PubMed ID: 11801453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.
    Jaberi-Douraki M; Pietropaolo M; Khadra A
    J Theor Biol; 2015 Oct; 383():93-105. PubMed ID: 26271890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
    Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
    Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.
    Aghili B; Amirzargar AA; Rajab A; Rabbani A; Sotoudeh A; Assadiasl S; Larijani B; Massoud A
    Iran J Immunol; 2015 Dec; 12(4):240-51. PubMed ID: 26714416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice.
    Ramakrishnan P; Yui MA; Tomalka JA; Majumdar D; Parameswaran R; Baltimore D
    Diabetes; 2016 Aug; 65(8):2367-79. PubMed ID: 27217485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?
    Askenasy N
    Immunol Res; 2016 Feb; 64(1):36-43. PubMed ID: 26482052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation and enrichment of mouse insulin-specific CD4
    Đedović N; Paunović V; Stojanović I
    J Immunol Methods; 2019 Jul; 470():46-54. PubMed ID: 31039339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High Thymic Output of Effector CD4
    Zhao Y; Alard P; Kosiewicz MM
    J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apoptotic non-beta cells suppress beta cell antigen-reactive T cells and induce beta cell antigen-specific regulatory T cells.
    Xia CQ; Qiu Y; Peng R; Lo-Dauer J; Clare-Salzler MJ
    Ann N Y Acad Sci; 2008 Dec; 1150():167-70. PubMed ID: 19120288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes.
    Hope CM; Welch J; Mohandas A; Pederson S; Hill D; Gundsambuu B; Eastaff-Leung N; Grosse R; Bresatz S; Ang G; Papademetrios M; Zola H; Duhen T; Campbell D; Brown CY; Krumbiegel D; Sadlon T; Couper JJ; Barry SC
    Eur J Immunol; 2019 Aug; 49(8):1235-1250. PubMed ID: 31127857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.